神经退行发生在聚合积累和去除之间的细胞临界点
bioRxiv : the preprint server for biology
|October 3, 2025
概括
由蛋白质聚合物的积累和去除平衡所驱动的细胞临界点是理解神经退行性疾病 (如阿尔茨海默氏症和帕金森氏症) 的关键. 这一发现为疾病机制和治疗开发提供了一个统一的框架.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 蛋白质聚合物是神经退行性疾病的常见特征.
- 在了解分子聚合如何导致疾病方面存在差距.
- 对神经退行症的机制性见解是有限的.
研究的目的:
- 建立一个神经退行症的通用细胞临界点模型.
- 将分子聚合动态与疾病表型联系起来.
- 开发治疗干预措施的预测框架.
主要方法:
- 开发了一种高通量活细胞试验,用于绘制细胞相位过渡的地图.
- 量化聚合物的积累和去除动态.
- 利用超高分辨率成像对阿尔茨海默氏症和帕金森病的大脑组织.
主要成果:
- 确定了细胞临界点作为神经退行性疾病中普遍的特征.
- 证明疾病状态会改变聚合物积累和去除之间的平衡.
- 验证了一个框架,预测聚合抑制剂如何恢复细胞平衡.
结论:
- 细胞的临界点提供了蛋白质聚合和神经退行之间的机械联系.
- 这一框架使得这些疾病的定量和统一理解成为可能.
- 这种方法有助于预测聚合抑制剂的治疗疗效.
更多相关视频
相关概念视频
Neurogenesis and Regeneration of Nervous Tissue
1.6K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.6K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Amyloid Fibrils
11.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.6K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


